Products

Home » Products » Elisa Kit » Human » Human TGF-β1(Transforming Growth Factor Beta 1) ELISA Kit

Human TGF-β1(Transforming Growth Factor Beta 1) ELISA Kit

Human

EH0287 Catalogue No.

Alias:: TGF-β1 ELISA Kit, Transforming Growth Factor Beta 1 ELISA Kit, TGF-B1 ELISA Kit, TGFB ELISA Kit, TGFbeta ELISA Kit, CED ELISA Kit, DPD1 ELISA Kit, TGFβ1 ELISA Kit
Reactivity:: Human
Range:: 31.25-2000pg/ml
Sensitivity:: 18.75pg/ml

Manual

Specifications
Publications
FAQs

Product Name

Human TGF-β1(Transforming Growth Factor Beta 1) ELISA Kit

Catalogue No.

EH0287

Alias

TGF-β1 ELISA Kit, Transforming Growth Factor Beta 1 ELISA Kit, TGF-B1 ELISA Kit, TGFB ELISA Kit, TGFbeta ELISA Kit, CED ELISA Kit, DPD1 ELISA Kit, TGFβ1 ELISA Kit

Detection Method

Sandwich ELISA, Double Antibody

Application

TGF-β1 ELISA Kit allows for the in vitro quantitative determination of TGF-β1 concentrations in serum, plasma, tissue homogenates and other biological fluids.

Size

96T

Range

31.25-2000pg/ml

Sensitivity

< 18.75pg/ml

Species

Human

UniProt ID

Standard curve

Storage

2-8 ℃ for 6 months

Recovery

Matrices listed below were spiked with certain level of TGF-β1 and the recovery rates were calculated by comparing the measured value to the expected amount of TGF-β1 in samples.

Matrix	Recovery range(%)	Average(%)
serum(n=5)	85-102	95
EDTA plasma(n=5)	96-104	99
heparin plasma(n=5)	92-102	97

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of TGF-β1 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample	1:2	1:4	1:8
serum(n=5)	89-95%	89-103%	85-103%
EDTA plasma(n=5)	92-101%	86-101%	86-95%
heparin plasma(n=5)	81-97%	80-99%	85-100%

CV(%)

Intra-Assay: CV<8%
Inter-Assay: CV<10%

Note

For Research Use Only

Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment
Date: 28/07/2023 IF: 11.3
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance
Date: 02/12/2022 IF: 8.756
Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes
Date: 18/03/2022 IF: 7.561
DOP03 The correlation of regulatory miRNAs with cytokine serum levels and cytokine genes’ polymorphisms
Date: 01/25/2019 IF: 6.992
A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study
Date: 15/09/2022 IF: 6.63
miR-10 and Its Negative Correlation with Serum IL-35 Concentration and Positive Correlation with STAT5a Expression in Patients with Rheumatoid Arthritis
Date: 29/07/2022 IF: 6.208
Integrated Analysis of Cytokine Profiles in Malaria Patients Discloses Selective Upregulation of TGF-β1, β3, and IL-9 in Mild Clinical Presentation
Date: 27/10/2022 IF: 6.208
Platelet Rich Fibrin (PRF) and Its Related Products: Biomolecular Characterization of the Liquid Fibrinogen
Date: 12/04/2020 IF: 5.688
Human Dental Pulp Mesenchymal Stem Cell-Derived Soluble Factors Combined with a Nanostructured Scaffold Support the Generation of a Vascular Network In Vivo
Date: 08/09/2023 IF: 5.3
Effects of adipose-derived mesenchymal stem cell conditioned medium on human tenocytes exposed to high glucose
Date: 12/01/2024 IF: 4.2
Relation between microRNA‐155 and inflammatory mediators in multiple sclerosis
Date: 27/10/2023 IF: 3.6
The impact of local and systemic penicillin on antimicrobial properties and growth factor release in platelet-rich fibrin: In vitro study
Date: 26/01/2024 IF: 3.4
Long noncoding RNA (taurine upregulated gene 1) and micro RNA-377: emerging players in the development of metabolic syndrome among psoriasis patients
Date: 28/07/2023 IF: 3.1
Effect of Different Dentin Conditioning Agents on Growth Factor Release, Mesenchymal Stem Cell Attachment and Morphology
Date: 04/12/2019 IF: 2.833
Low serum level of 25‐OH vitamin D relates to Th17 and treg changes in colorectal cancer patients
Date: 04/11/2022 IF: 2.493
Pilot study investigating diagnostic utility of serum MMP-1 and TGF-β1 in asthma in ‘real world’ clinical practice in India
Date: 06/05/2021 IF: 2.46
Adalimumab and methotrexate affect the concentrations of regulatory cytokines (interleukin‐10, transforming growth factor‐β1, and interleukin‐35) in patients with plaque psoriasis
Date: 07/08/2020 IF: 2.327
ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosis
Date: 08/10/2023 IF: 2.2
The effects of anti-PD-L1 monoclonal antibody on the expression of angiogenesis and invasion-related genes
Date: 22/09/2023 IF: 2.2
Cryopreserved, Thin, Laser-Etched Osteochondral Allograft maintains the functional components of articular cartilage after 2 years of storage
Date: 19/11/2020 IF: 1.777
Impact of the harsh Antarctic environment on mucosal immunity
Date: 24/09/2021 IF: 1.638
Can TGF-Β1 Be an Important Prognostic Factor in Predicting Covid-19 Disease Severity?
Date: 07/04/2022 IF: 0
Increase of Transforming Growth Factor-Beta 1 in Gingival Crevicular Fluid during Human Orthodontic Tooth Movement
Date: 28/09/2023 IF: 0
FEATURES OF THE AMINO ACID COMPOSITION OF BLOOD PLASMA AND THE CONTENT OF TRANSFORMING GROWTH FACTOR-Β1 IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE AND OBSTRUCTIVE SLEEP APNEA/HYPOPNEA SYNDROME
Date: 26/01/2021 IF: 0
Mesenchymal Stem Cells Suppress Tgf-β Release to Decrease Α- Sma Expression in Ameliorating Ccl4-Induced Liver Fibrosis
Date: 20/05/2020 IF: 0
In vitro regulation of IL-6 and TGF-ß by mesenchymal stem cells in systemic lupus erythematosus patients
Date: 15/06/2020 IF: 0
Levels of Tumor Necrosis Factor-α (TNF-α) and Transforming Growth Factor-β1 (TGF-β1) in Gingival Crevicular Fluid During Canine Retraction Using Elastic Chain and Closed Coil Spring
Date: 07/13/2018 IF: 0
Effect of Viscum album extract on angiogenesis mediators and cytokines in Egyptian patients with intermediate hepatocellular carcinoma
Date: 18/06/2021 IF: 0
The Influence of Obstructive Sleep Apnea/Hypopnea Syndrome on the Levels of Proinflammatory and Profibrotic Cytokines in Patients with Gastroesophageal Reflux Disease
Date: 15/08/2019 IF: 0
Urinary TGF-β1 was not independently associated with renal function in diabetes mellitus
Date: 10/26/2018 IF: 0
Possible Protective Effect of Onion Supplementation on Hepatic Functional and Structural Alterations Induced by Cholestasis
Date: 19/12/2019 IF: 0
The relationship between coronavirus disease-2019-positive patients and plasma interleukins and transforming growth factor-β levels
Date: 13/01/2023 IF: 0

Elisa Kit FAQs